Autoplay
Autocomplete
Previous Lesson
Complete and Continue
Hyperadrenocorticism and Hypoadrenocorticism in 2023
Section 1 - Hyperadrenocorticism in 2023
drip alpha - Transcript and Slide Deck
drip 1 - Meet Dexter (6:42)
drip 2 - Cushing's Etiology (6:21)
drip 3 - Cushing's Signs and Symptoms (7:50)
drip 4 - Diagnostic Testing for Cushing's (7:03)
Poll Question #1
drip 5 - More on Testing (10:43)
drip 6 - Diagnostic Imaging (4:52)
Poll Question #2
drip 7 - Therapies (7:03)
drip 8 - Trilostane (4:24)
Poll Question #3
drip 9 - Trilostane Continued (8:49)
drip 10 - Concluding Points (7:35)
drip 11 - Hyperadrenocorticism Q & A Part 1 (10:21)
drip 12 - More Hyperadrenocorticism Cases (7:58)
drip 13 - Hyperadrenocorticism Cases Continued (9:35)
drip 14 - Last Hyperadrenocorticism Cases (8:21)
drip 15 - Two More Variations (8:21)
drip 16 - Hyperadrenocorticism Q & A Part 2 (2:13)
Section 2 - Hypoadrenocorticism in 2023
drip alpha - Slide Deck
drip 1 - Hypoadrenocorticism (7:26)
Poll Question #4
drip 2 - Understanding Primary vs. Secondary (6:56)
drip 3 - Studies of Interest (8:36)
drip 4 - Treatment (7:51)
Poll Question #5
drip 5 - Two Approaches (6:48)
drip 6 - Wrap-Up (4:52)
drip 7 - Addison's Q & A (3:43)
Post-Course Assessment Hyperadrenocorticism and Hypoadrenocorticism in 2023
Post-Course Assessment Hyperadrenocorticism and Hypoadrenocorticism in 2023
drip 9 - Trilostane Continued
Lesson content locked
If you're already enrolled,
you'll need to login
.
Enroll in Course to Unlock